The Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, Second Edition, edited by FHCI's Neuro-Oncology Medical Director Herbert Newton, MD, FAAN, provides a comprehensive overview on the use of chemotherapy and molecular therapeutics for brain tumor treatment, compiling the most recent research findings within the field into a single book. Available at www.elsevier.com, the new book includes:
- Up-to-date information on conventional forms of cytotoxic chemotherapy as well as the basic science and clinical application of molecular therapeutics for the treatment of brain tumors
- New material on molecular methods in chemotherapy and the field of neuro-oncology
- Updated chapters on molecular biology, molecular therapeutics, maturation of immunotherapy approaches, and multidisciplinary molecular methods
- A new section on the basic science of immunology as well as updates on the use of vaccine technology and immunotherapy for the treatment of brain tumors
We are in the midst of a molecular oncology revolution, said Dr. Newton. This was a landmark book when it was published 10 years ago, and the second edition has doubled in size in order to cover all of the new developments in brain tumor treatment, including molecular genetics and biology, vaccines, immunotherapy, and the combination of these new treatment modalities with chemotherapy. This is a valuable resource for anyone treating brain cancer patients to help provide them with the best possible care.
FHCI's Herbert Newton, MD, is a board-certified neuro-oncologist and neurologist who was named medical director of FHCI's Brain and Spine Cancer Program after more than 30 years of experience in the fields of neuro-oncology and neurology. Dr. Newton specializes in the diagnosis and treatment of brain and spinal cord tumors in both adults and adolescent patients, and in complex treatment plans, including the use of chemotherapy and molecular therapeutics. He has been recognized by Newsweek as one of Americas Top Doctors for Cancer (2005-2015) and is a former Chair of the American Academy of Neurology Section of Neuro-Oncology. Over the course of his career, he has published more than 200 peer-reviewed publications, as well as 9 medical textbooks.
Dr. Newton earned his medical degree from SUNY-Buffalo Medical School in Buffalo, New York, and completed his residency in neurology at the University of Michigan Medical Center. He also completed a fellowship in neuro-oncology at the Memorial Sloan-Kettering Cancer Center in New York. Prior to his arrival at FHCI, he was the Director of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital for more than 20 years.
For more information or to refer a patient, call Brain/Spinal Care Coordinator Denal Wilson, BSN, RN, OCN, at